Acute myocardial infarction in the elderly with diabetes

Heart and Lung: Journal of Acute and Critical Care

Volumn 31, Issue 5, 2002, Pages 327-339

  Chyun, Deborah ^a   Vaccarino, Viola ^b   Murillo, Jaime ^c   Young, Lawrence H ^d   Krumholz, Harlan M ^d  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^b EMORY UNIVERSITY   (United States)

^c Cardiology Consultants Ltd   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LIPID;

ACUTE HEART INFARCTION; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OLIGURIA; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; RETROSPECTIVE STUDY; THORAX PAIN;

EID: 0036732638     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhl.2002.126049     Document Type: Article

References (90)

1. Myocardial infarction prognosis by discriminant analysis
2. Diabetes mellitus and myocardial infarction
3. High mortality in obese women diabetics with acute myocardial infarction
4. Effect of diabetes mellitus on the course of acute myocardial infarction in men
5. Clinical course of myocardial infarction among diabetic subjects
6. Diabetic myocardial infarction: Interaction of DM with other preinfarction risk factors
7. Experience of coronary care in diabetics
8. Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction
9. Myocardial infarction in subjects with diabetes mellitus
10. Determinants of hospital arrival and case fatality in diabetic subjects with myocardial infarction
11. Diabetic subjects and myocardial infarction
12. Trends in prevalence of diabetes mellitus subjects with myocardial infarction and effect of diabetes on survival: The Minnesota Heart Survey
13. The influence of sex and diabetes mellitus on survival following acute myocardial infarction: A community-wide perspective
14. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites: The Corpus Christi Heart Project
15. Effect of diabetes mellitus on short- and long-term mortality rates of subjects with acute myocardial infarction: A statewide study
16. The impact of diabetes on survival among subjects with first myocardial infarction
17. Significance of diabetes mellitus in subjects with acute myocardial infarction receiving thrombolytic therapy
18. Outcome of subjects with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents
19. Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study
20. Ten-year survival after acute MI; comparison of subjects with and without diabetes
21. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction
22. Myocardial infarct size in diabetic subjects
23. Prognostic importance of arrival plasma glucose in diabetic and nondiabetic subjects with acute myocardial infarction
24. Myocardial infarction in diabetics
25. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to adverse prognosis
26. Impact of diabetes on mortality after the first myocardial infarction
27. Effects of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project)
28. Angiographic findings and outcome in diabetes patients treated with thrombolytic therapy for acute myocardial infarction: The GUSTO-1 experience
29. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry
30. Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction
31. Acute myocardial infarction in diabetic subjects
32. Myocardial infarction in old people: The influence of diabetes mellitus
33. Diabetes mellitus and acute myocardial infarction
34. Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction
35. Age-related differences in case-fatality rates among diabetic subjects with myocardial infarction: Findings from the National Hospital Discharge Survey, 1979-1987
36. A matched case-control study of in-hospital mortality in subjects with diabetes and acute myocardial infarction
37. Prevalence of diabetes mellitus, impaired fasting glucose tolerance in US adults: The Third National Health and Nutrition Examination Survey, 1988-1994
38. Quality of care for medicare subjects with acute myocardial infarction: A four-state pilot study from the Cooperative Cardiovascular Project
39. Chi-square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure
40. Non-parametric estimation from incomplete observation
41. Regression models and life tables
42. Analysis with multiple levels of exposure
43. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction
44. Glycometabolic state at admission; important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction
45. Sex differences in mortality after acute myocardial infarction: Evidence for a sex-age interaction
46. Sex-based differences in early mortality after myocardial infarction
47. Long-term prognostic value of clinically evident noncoronary vascular disease in subjects undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI)
48. Using arrival characteristics to predict short-term mortality from myocardial infarction in elderly subjects
49. Course and prognosis in subjects > 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction
50. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor
51. Increased congestive heart failure after myocardial infarction of modest extent in subjects with diabetes mellitus
52. Heart failure and recurrent myocardial infarction in the elderly with diabetes
53. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
54. Predictors of death during 5 years after discharge among patients with a suspected acute coronary syndrome with particular emphasis on whether an infarction was developed
55. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
56. Incidence and prognosis of unrecognized myocardial infarction
57. Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy
58. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction
59. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
60. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes
61. Outcome of unstable angina inpatients with diabetes mellitus
62. Diabetic treatment and primary ventricular fibrillation in acute myocardial infarction
63. Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes
64. Aspirin use among adults with diabetes
65. National use and effectiveness of β-blockers for the treatment of elderly patients with acute myocardial infarction: National Cooperative Cardiovascular Project
66. Beta-blocker prescribing differences in patients with and without diabetes following a first myocardial infarction
67. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
68. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
69. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: Subgroup analyses in the cholesterol and recurrent events (CARE) trial
70. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
71. Diabetic patients and β-blockers after acute myocardial infarction
72. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction
73. Uniformity of captopril benefit in the SAVE Study: Subgroup analysis
74. Aspirin effects on mortality and morbidity in patients with diabetes mellitus
75. Effects of intensive blood-pressure lowering and low dose aspirin on patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial
76. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease
77. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)
78. Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: Results form the Platelet Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study
79. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy. Global Use of Strategies to Open occluded arteries in acute coronary syndromes
80. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
81. Diabetes mellitus and exercise
82. Management of dyslipidemia in adults with diabetes
83. Aspirin therapy in diabetes
84. Treatment of hypertension in adults with diabetes
85. Report of the expert committee on the diagnosis and classification of diabetes mellitus
86. Clinical impact of borderline and undiagnosed diabetes mellitus in patients with coronary artery disease